Non-targeted proteomics of acute respiratory distress syndrome: clinical and research applications.

ABSTRACT: Acute respiratory distress syndrome (ARDS) is characterized by refractory hypoxemia caused by accumulation of pulmonary fluid with a high mortality rate, but the underlying mechanism is not yet fully understood, causing absent specific therapeutic drugs to treat with ARDS. In recent years, more and more studies have applied proteomics to ARDS. Non-targeted studies of proteomics in ARDS are just beginning and have the potential to identify novel drug targets and key pathways in this disease. This paper will provide a brief review of the recent advances in the application of non-targeted proteomics to ARDS.

SUBMITTER: Wen XP 

PROVIDER: S-EPMC7980750 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature